Abstract-During development of the calcitonin binding assay using rat brain particulate fraction, it was noticed that 1251-salmon calcitonin
and it is not rare that nonspecific absorption by the surface with which the ligand comes in contact presents a serious problem. Recently we characterized the calcitonin-specific binding site in the rat brain as exhibiting a high regional variation and low KDs (1, 2).
Our observations were later confirmed by other investigators (3) . In our studies, it was noticed that calcitonin was easily lost by absorption to the polypropylene tube (see the footnote) used for the binding assay. The use of bacitracin, employed expecting inhibition of absorption and enzymatic degradation of 1251-SCT, has enabled us to characterize the calcitonin-specific binding site, but the necessity of a better agent as a substitute for bacitracin had been keenly felt.
In this paper, we report that bacitracin can be replaced by some detergents such as Triton X-100
and Brij 36T, and these detergents would be also useful in radio receptor assays of other physiologically important peptides.
MATERIALS AND METHODS

Human 8-endorphin was a generous gift
The material of the tube was described to be polyethylene in our previous report (1) based on wrong information from the manufacturer, but the actual material of the tube was polypropylene.
It should be noted that the polyethylene tube from the same maker (Sample Cup 1A) also exhibited a similar binding property for 1251-SCT. (Boston, U.S.A.). Commercially available Triton X-100 and Brij 36T contain con siderable amounts of dithiothreitol-oxidizing activity (4). This activity was able to be removed by incubating a 1 % (w/v) solution of the detergent in Tris-HCI buffer (pH 7.4) containing 10 mM methionine and 1 mM EDTA at 4°C overnight.
Measurement of 1251-SCT binding: 1251 SCT was prepared as described (1) . For estimation of the binding to the poly propylene tube, the tube contained in 1 .0 ml of 50 mM Tris-HCI buffer (pH 7.4), 1.0 pmole of 1251-SCT (0.9X105 cpm), and 0 or 1 aM of SCT. After incubation at 4°C for 30 min, the supernatant was removed by decantation. The tube was washed once with buffer, 2% SDS solution added, and incubated at 60°C overnight. The radio activities in the supernatant, in the washing buffer, and in the SDS solution were estimated. The rat brain particulate fraction was prepared from a homogenate of lower brain regions (hypothalamus, medulla oblongata, midbrain and pons) of Wistar male rats (150-170 g) as described (1) . Binding assay conditions were the same as used above except that the tube additionally contained 1.6 mg protein of the particulate fraction and before decantation, the 1251 SCT-bound fraction was pelleted by centri fuging at 15,000xg for 30 min. Tissue protein was quantified by the method of Lowry et al. (5) for 10 min, and the pellet suspended in the buffer was used as the P2 membrane fraction.
The binding assay was carried out in a polypropylene tube as described by Terenius (7) . The reaction mixture contained in 1.0 ml of Tris-HCI buffer (pH 7.4), 2 pmole of [3H]-naloxone, membrane fraction (0.80 mg protein), and 4-endorphin (0-1.0 W), in the presence or absence of 0.0003% Brij 36T. The presence also means here that dilution and pipetting of (9-endorphin were carried out in the buffer containing 0.003% detergent.
The reaction mixture was incubated at 37'C for 30 min and centrifuged at 15,000 x g for 10 min. The pellet was solubilized by Protosol for counting.
The specific binding was designated as the binding inhibited by 1 iiM morphine.
RESULTS
1251-SCT absorption to assay tube: pro tection by SCT and brain particulate fraction: Since 1251-SCT was prepared and diluted in the presence of Triton X-100, the reaction mixture invariably contained less than 0.00005% of the detergent as the final concentration.
In this concentration, the detergent did not inhibit 1251-SCT absorption by the tube. Table 1 shows a low recovery rate of 1251-SCT when the assay tube first received 1251-SCT and then buffer or SCT containing buffer.
In the absence of SCT, Throughout this experiment, SCT was the first addition to the tube which significantly increased the recovery of 1251-SCT in the supernatant plus washing and decreased the recovery in the SDS solution. The adding order of 1251-SCT (I, 8.8X104 cpm), buffer (II), and rat brain particulate fraction (III) which followed the SCT addition in the control, was in a) I and II, in b) I, II, and III, and in c) III, I, and Il.
the rate was only 38%. The low recovery rate is not due to absorption to the pipet tip which is also made of polypropylene because the radioactivity of 1251-SCT in In addition to bacitracin, Triton X-100, Brij 36T, and the two Zwittergents 3-14 and 3-16 were found to have such an abolishing effect in relatively dilute concentrations (Fig. 1) The order of adding to the assay tube was a candidate-containing buffer, 1251-SCT, and then the tissue fraction. I n the control, SCT was added after the buffer. In the concentration ranges which nullified the SCT-inhibited absorption to the tube (refer to Fig. 1) , Triton X-100, Brij 36T, and bacitracin were able to depress the SCT inhibited binding to a certain level (Figs. 2  and 3 ) which corresponded to the binding estimated above in the absence of any anti absorbant by first adding the tissue fraction to the tube (Table 1, SCT binding to the rat brain particulate fraction.
•, Triton X-100 and A, BSA. Each point represents the mean±S.E. of 2 triplicate deter minations. The solid line was obtained in the absence of SCT and the broken in the presence. protein has been widely used in radioreceptor assays of various peptide hormones including SCT. Rizzo and Goltzman (3) carried out a binding assay of calcitonin in the presence of 2% BSA. As stated previously (1) and also shown here, 1 % BSA failed to abolish non specific absorption of 1251-SCT to the poly propylene tube. In contrast, the presence of the brain fraction itself was able to minimize such unwanted absorption. Though the nature of the protecting effect is not known, it is possible that the brain fraction contains myelin basic protein which allowed Ferrara et al. (9) to apply the filtration method for the binding assay of ;3-endorphin.
In conclusion, it is suggested that for developing a radioreceptor assay for a basic and lipophylic peptide, special care must be taken to avoid non-specific absorption by experimental tools, and a recommended method for the calcitonin binding assay is carrying out the whole assay procedure only in the presence of Brij 36T or its substitute.
